Loading...
Health economics in the field of osteoarthritis: An expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Hiligsmann, Mickaël Cooper, Cyrus Arden, Nigel Boers, Maarten Branco, Jaime C. Brandi, Maria Luisa Bruyère, Olivier Guillemin, Francis Hochberg, Marc C. Hunter, David J.
Hiligsmann, Mickaël
Cooper, Cyrus
Arden, Nigel
Boers, Maarten
Branco, Jaime C.
Brandi, Maria Luisa
Bruyère, Olivier
Guillemin, Francis
Hochberg, Marc C.
Hunter, David J.
Author
Hiligsmann, Mickaël
Cooper, Cyrus
Arden, Nigel
Boers, Maarten
Branco, Jaime C.
Brandi, Maria Luisa
Bruyère, Olivier
Guillemin, Francis
Hochberg, Marc C.
Hunter, David J.
Kanis, John A.
Kvien, Tore K.
Laslop, Andrea
Pelletier, Jean-Pierre
Pinto, Daniel
Reiter-Niesert, Susanne
Rizzoli, Rene
Rovati, Lucio C.
Severens, Johan L.
Silverman, Stuart
Tsouderos, Yannis
Tugwell, Peter
Reginster, Jean-Yves
Cooper, Cyrus
Arden, Nigel
Boers, Maarten
Branco, Jaime C.
Brandi, Maria Luisa
Bruyère, Olivier
Guillemin, Francis
Hochberg, Marc C.
Hunter, David J.
Kanis, John A.
Kvien, Tore K.
Laslop, Andrea
Pelletier, Jean-Pierre
Pinto, Daniel
Reiter-Niesert, Susanne
Rizzoli, Rene
Rovati, Lucio C.
Severens, Johan L.
Silverman, Stuart
Tsouderos, Yannis
Tugwell, Peter
Reginster, Jean-Yves
Abstract
Methods: The ESCEO expert working group met to discuss the epidemiological and economic evidence that justifies the increasing concern of the impact of this disease and reviewed the current state-of-the-art in health economic studies in this field. Results: OA is a debilitating disease; it is increasing in frequency and is associated with a substantial and growing burden on society, in terms of both burden of illness and cost of illness. Economic evaluations in this field are relatively rare, and those that do exist, show considerable heterogeneity of methodological approach ( such as indicated population, comparator, decision context and perspective, time horizon, modeling and outcome measures used ). This heterogeneity makes comparisons between studies problematic. Conclusions: Better adherence to guidelines for economic evaluations is needed. There was strong support for the definition of a reference case and for what might constitute “standard optimal care” in terms of best clinical practice, for the control arms of interventional studies.
Keywords
review, cost-effectiveness, cost–utility, osteoarthritis, arthroplasty, economics, methods
Date
2013
Type
Journal article
Journal
Seminars in Arthritis and Rheumatism
Book
Volume
43
Issue
3
Page Range
303-313
Article Number
ACU Department
Mary MacKillop Institute for Health Research
Faculty of Health Sciences
Faculty of Health Sciences
Collections
Relation URI
Source URL
Event URL
Open Access Status
Open access
License
File Access
Controlled
Notes
© 2013 The Authors. Published by Elsevier HS Journals. Open access under CC BY license.